Investigating the effect of auricular acupressure on pain, quality of life and peripheral neuropathy caused by chemotherapy

Investigating the effect of auricular acupressure on pain, quality of life and peripheral neuropathy caused by chemotherapy among the elderly with breast cancer referred to centers affiliated to Kerman University of Medical Sciences

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211213053389N2

Enrollment

Registered

2024-10-24

Start date

2024-10-12

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: In the intervention group, auricular acupressure will be applied on 3 common ear points, including the spleen, liver, and spleen, and 1 point related to the finger

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: Undergoing chemotherapy, including taxane agents (such as docetaxel and paclitaxel) Elderly over 65 years old Reported a score greater than five on a numerical rating scale for pain symptoms in the past week (indicating more severe than average pain) Possibility to participate in the plan for four weeks The ability to communicate and the absence of speech and hearing problems

Exclusion criteria

Exclusion criteria: 12 months or more have passed since the end of their chemotherapy treatment They had skin inflammation, or used hearing aids, or had piercings or holes in the intervention sites During the study period, they are under chemotherapy or radiotherapy Ear acupressure experience within 3 months before participating in the study Metastatic cancer status Have psychiatric diseases or other diseases that can affect this study (Alzheimer's, delirium, rheumatoid arthritis)

Design outcomes

Primary

Measure	Time frame
Chemotherapy-induced peripheral neuropathy score in Chemotherapy-Induced Peripheral Neuropathy-20 (CIPN-20), health-related quality of life score in Functional Assessment of Cancer Therapy-General (FACT-G), pain score in The Numeric Rating Scale. Timepoint: Questionnaires are given to the participants before the intervention, immediately after the end of the intervention and two weeks after the end of the intervention, or they are completed with an interview. Method of measurement: Chemotherapy-Induced Peripheral Neuropathy-20 questionnaires (CIPN-20), Functional Assessment of Cancer Therapy-General questionnaires (FACT-G), The Numeric Rating Scale.	—

Measure

Time frame

Chemotherapy-induced peripheral neuropathy score in Chemotherapy-Induced Peripheral Neuropathy-20 (CIPN-20), health-related quality of life score in Functional Assessment of Cancer Therapy-General (FACT-G), pain score in The Numeric Rating Scale. Timepoint: Questionnaires are given to the participants before the intervention, immediately after the end of the intervention and two weeks after the end of the intervention, or they are completed with an interview. Method of measurement: Chemotherapy-Induced Peripheral Neuropathy-20 questionnaires (CIPN-20), Functional Assessment of Cancer Therapy-General questionnaires (FACT-G), The Numeric Rating Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad hossein Khajehpour

Kerman University of Medical Sciences

Khajehpoor_m@yahoo.com+98 34 3132 5219

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026